| 摘要 |
A method is disclosed for inhibiting complement activation in brain-dead organ donors, particularly kidney donors, which leads to improvement of organ function of transplanted organs in recipients. The method involves administration of a complement inhibitory protein, specifically a soluble complement receptor type 1 (sCR1) polypeptide to the donor prior to harvesting the organ for transplant. |
